| 摘要 |
The present invention relates to a method for predicting the response to administration of a chemotherapeutic or biological therapeutic agent consisting of tyrosine kinase inhibitors to an individual, comprising detecting the amount of one or a plurality of biological markers in a tissue or cell sample originating from the individual, wherein the biological markers are cellular components to the c-kit pathway and comparing the amount of the one or the plurality of biological markers detected in subpart (a) with the amount detected in one or a plurality of control tissue or cell samples, wherein a response to the administration of a chemotherapeutic or biological therapeutic agent to an individual is predicted based on the comparison of the amount of the one or the plurality of biological markers from one or a plurality of control tissue or cell samples. |
